Company: IMCR
Filing Date: 2025-04-04
Form Type: DEF 14A
Source: 0001140361-25-012123
Chunk: 84

Company: Immunocore Holdings plc
Filing Date: 2025-04-04
Form: DEF 14A
Chunk 84
---
 |     | 2/15/2032  |
|                |     | 2/16/2023  |     | 2/16/2023    |     |           39,637 |     |           50,962 |     |    64.53 |     | 2/15/2033  |
|                |     | 2/16/2024  |     | 2/16/2024    |     |                — |     |          111,244 |     |    70.50 |     | 2/15/2034  |
| Tina St. Leger |     | 4/1/2022   |     | 4/1/2022     |     |            8,750 |     |           26,250 |     |    29.87 |     | 3/31/2032  |
|                |     | 2/16/2023  |     | 2/16/2023    |     |            5,835 |     |            7,503 |     |    64.53 |     | 2/15/2033  |
|                |     | 2/16/2024  |     | 2/16/2024    |     |                — |     |           14,162 |     |    70.50 |     | 2/15/2034  |

| (1) | All of the awards in this table granted prior to February 4, 2021 were granted under our pre-IPO equity incentive plans, and all awards in this table granted on or subsequent to February 4, 2021 were granted under the 2021 EIP. |

| (2) | Twenty-five percent of the ordinary shares subject to this award vested or vest on the first anniversary of the vesting commencement date, and the remaining shares vest in 12 equal quarterly installments thereafter, subject to the named executive officer’s continued service through each vesting date. |

| (3) | Mr. Di Donato’s unvested, unexercised options forfeited upon his resignation from employment with us effective December 31, 2024. Mr. Di Donato’s post-termination exercise period allowed for the exercise of his unexercised, vested options through March 31, 2025. |

Option Exercises and Stock Vested The following